Current Hematologic Malignancy Reports (ISSN 1558-8211, 1558-822X) is a journal published by Springer Nature in the United States. It covers Biochemistry, Genetics and Molecular Biology, Medicine and Hematology. It is indexed in Scopus, Web of Science, PubMed and HEC. Recorded metrics: impact factor 4, Scopus Q1, Web of Science Q2, CiteScore 6.6 and HEC W-Category. Article processing charge: USD 3,990.
Current Hematologic Malignancy Reports
Record last updated . Check current status at HEC HJRS, Scopus and the Web of Science Master Journal List before submitting. About our data.
Journal lists: Q1 journals · Q2 journals · HEC W category journals · Scopus journals · Web of Science journals · PubMed journals · SCImago journals · SCIE journals
Quick answers about Current Hematologic Malignancy Reports
Is Current Hematologic Malignancy Reports HEC recognised?
Yes. The catalogue records Current Hematologic Malignancy Reports in HEC category W of the HEC Journal Recognition System, where W is the highest and Y the lowest category. Confirm the current category on HEC's HJRS website before you submit.
Is Current Hematologic Malignancy Reports indexed in Scopus?
Yes. Current Hematologic Malignancy Reports is listed as Scopus-indexed, in quartile Q1, with a CiteScore of 6.6. Check its current status on the Scopus Sources page.
Is Current Hematologic Malignancy Reports in Web of Science?
Yes. Current Hematologic Malignancy Reports is listed as a Web of Science journal in the Science Citation Index Expanded (SCIE), with Web of Science quartile Q2. Confirm on Clarivate's Master Journal List.
What is the impact factor of Current Hematologic Malignancy Reports?
The recorded journal impact factor of Current Hematologic Malignancy Reports is 4. Clarivate updates impact factors every year in Journal Citation Reports.
Is Current Hematologic Malignancy Reports open access, and what does it charge?
Current Hematologic Malignancy Reports is not recorded as fully open access and its APC is USD 3,990. Fees change, so check the journal's website before you submit.
Who publishes Current Hematologic Malignancy Reports?
Current Hematologic Malignancy Reports is published by Springer Nature in United States, under ISSN 1558-8211 and 1558-822X.
Browse similar journals
- Biochemistry journals (2,272)
- Genetics and Molecular Biology journals (2,274)
- Medicine journals (8,023)
- Journals indexed in Scopus (31,185)
- Journals indexed in Web of Science (22,643)
- Journals indexed in PubMed (16,086)
- Journals indexed in HEC (34,823)
- Scopus Q1 journals (9,924)
- Web of Science Q2 journals (5,019)
- HEC W-Category journals (13,616)
- Journals published in the United States (7,575)
- Springer Nature journals (2,655)